Proliferative diseases of the uterus. What to prefer in the postoperative rehabilitation program?

N.A. Shchukina, S.N. Buyanova, E.L. Babunashvili, N.Yu. Zemskova, T.A. Glebov, D.Yu. Son, A.A. Kochetkova, A.G. Bespalova
In: Russian Bulletin of Obstetrician-Gynecologist · 2023 · vol. 23(5) , pp. 100 · doi:10.17116/rosakush202323051100 · W4387507551
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

Proliferative uterine diseases (uterine myoma, endometriosis) and their combination are not uncommon pathology, which, along with surgery, requires a medical component of treatment. This article highlights new aspects of clinical manifestations of these diseases («rejuvenation» of the contingent, increase in the frequency of rare forms of endometriosis — its affection of the anterior abdominal wall and uterine scar), on the basis of the latest clinical recommendations of the Russian Federation on the treatment of patients with uterine myoma, endometriosis, as well as on the basis of many years of our own experience of treatment and postoperative rehabilitation of patients are considered and given variants of differentiated postoperative drug therapy (gonadotropin-releasing hormone agonists).

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK